• ChemoMetec held its annual general meeting on Oct. 8, 2026.
• Shareholders adopted the 2025/26 annual report, endorsed the board’s review of the year, and granted discharge to directors and executives.
• Profit appropriation was adopted, including a resolution to pay no dividend for 2025/26.
• Shareholders backed keeping the board at five members, then confirmed the existing directors for another term.
• PwC was appointed auditor, while authorization to buy back the company’s own shares was also adopted.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ChemoMetec A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610081357OMX_____CNEWS_EN_GNW1001277045_en) on October 08, 2026, and is solely responsible for the information contained therein.